Matthew Meriggioli to Prospective Studies
This is a "connection" page, showing publications Matthew Meriggioli has written about Prospective Studies.
Connection Strength
0.010
-
Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment. J Autoimmun. 2005 May; 24(3):261-8.
Score: 0.010
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.